ABCD trialCardiovascular disease
1. A prospective, randomized, blinded, clinical trial–Appropriate Blood Pressure Control in Diabetes–which compared, in type 2–NIDDM diabetics, 1. The efficacy of nisoldipine, a CCB, with enalapril, an ACE inhibitor, as 1st-line antihypertensive agents and.
2. The effects of moderate BP control–target–80-89 mm Hg vs 'tight' BP control–target–75 mm Hg on cardiovascular M&M. See Enalapril, Nisoldepine.
3. A clinical trial–Alternans Before Cardioverter-Defibrillator.